LOWER RESPONSE TO INTRAVESICAL ADJUVANT THERAPY IN HIGH-RISK BLADDER CANCER COULD BE RELATED TO THE UROTHELIAL EXPRESSION OF EGFR
- Authors: Cristina Scalici Gesolfo, Sebastiano Billone, Alessio Guarneri, Marco Vella, Alessandro Perez, Graziella Cangemi, Antonio Russo, Alchiede Simonato,Vincenzo Serretta
- Publication year: 2017
- Type: Abstract in atti di convegno pubblicato in rivista
- OA Link: http://hdl.handle.net/10447/265441